OmniAb, Inc. Common Stock

OABINASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
2.12 USD
↗ 0.08 (3.92%)AT CLOSE (11:59 AM EDT)
2.13
↗ 0.00 (0.24%)
POST MARKET (AS OF 05:51 PM EDT)
Post Market
AS OF 05:51 PM EDT
2.13
↗ 0.00 (0.24%)
🟢Market: OPEN

Shares of OmniAb, Inc. Common Stock (OABI) are trading at $2.09. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place OABI at a fair price relative to peers.

Technical & fundamental data as of Jul 17, 2026.

Open?$2.02
High?$2.16
Low?$1.95
Prev. Close?$2.04
Volume?500.4K
Avg. Volume?579.1K
VWAP?$2.11
Rel. Volume?0.86x
Bid / Ask
Bid?$2.01 × 100
Ask?$2.16 × 100
Spread?$0.15
Midpoint?$2.09
Valuation & Ratios
Market Cap?295.7M
Shares Out?145.0M
Float?74.8M
Float %?51.6%
P/E Ratio?N/A
P/B Ratio?1.13
EPS?-$0.37
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Themes
Biotech - Drug Development›Clinical-Stage PlatformsHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
89
Market Cap
295.7M
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Website
www.omniab.com
Listed
2022-11-01
Address
5980 HORTON STREET
EMERYVILLE, CA 94608
Phone: 510-250-7800
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
92
Short Sent.?
42
Piotroski F-Score?3/9Weak
Altman Z-Score?7.91Safe
Confidence?53%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?6.36%Elevated
Short Interest?4.8M
Days to Cover?6.4
Free Float74.8M
Avg Daily Volume746.1K
Settlement Date2026-06-30
Financial Health
Current Ratio?4.80Strong
Quick Ratio?4.80Strong
Cash Ratio?2.14Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
94
1.13CHEAP▾
P/S?
Peers
100
S&P
8
10.22HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-7.8CHEAP▾
EV/Sales?
Peers
100
S&P
13
9.22HIGH▾
Returns & Efficiency
ROE?
S&P
8
-20.7%WEAK▾
ROA?
S&P
3
-18.5%WEAK▾
Cash Flow & Enterprise
FCF?$-26854000
Enterprise Value?$266.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist